HomeCONGRESS

CONGRESS

View Category
Mitral valve

ACC 2023 | TRILUMINATE Pivotal: Edge-to-Edge Treatment in Patients with Tricuspid Regurgitation

Tricuspid regurgitation is a common and impairing disease. Optimal medical therapy (OMT) is limited, valve surgery is...
solaci -
Learn More
Chronic Ischemic cardiopathy

ACC 2023 | RENOVATE-COMPLEX-PCI: Intravascular Imaging-Guided vs. Angiography-Guided Complex PCI

Patients with complex coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) have worse clinical outcomes tan...
solaci -
Learn More
Chronic Coronary Syndromes

ACC 2023 | Complete Revascularization Strategies in patients with ACS and Multivessel Disease

In patients with acute coronary syndrome (ACS) and multivessel disease, complete revascularization is associated with better clinical...
solaci -
Learn More
Structural heart disease

ACC 2023 | TAVR in Low Risk Patients: 3-Year Outcomes

At present, transcatheter aortic valve replacement (TAVR) has become the gold standard in the US, regardless surgical...
solaci -
Learn More
Mitral valve

ACC 2023 | COAPT Study: 5 Year Followup after Transcatheter Repair of Secondary Mitral Regurgitation

The five year outcomes of the multicenter open label COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous...
solaci -
Learn More
ACC 2023

ACC 2023

Here are the most important scientific articles of the ACC 2023 Scientific Sessions. If you cannot view the...
solaci -
Learn More
SOLACI-SBHCI 2016 Presentations

Venus P-Valve: The valve and initial clinical worldwide experience

Por Dr. Alejandro Peirone.
solaci -
Learn More
SOLACI-SBHCI 2016 Presentations

FFR EM LESÕES SEQUENCIAIS E DOENÇA DIFUSA

Por Dr. Silvio Gioppato.  
solaci -
Learn More